Security record · archived quarter
ABSI
Absci Corporation · Healthcare · Biotechnology
13Tracked holders
0Δ holders
50.18MShares held
$128.95MReported value
+2New positions
−2Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -2.6% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 36.37K | $325,139 | n/a | n/a |
| Q2 2026 | 82 | +7 | 112.04M | $1.30B | +11 | −4 |
| Q1 2026 | 77 | +13 | 90.86M | $272.61M | +16 | −3 |
| Q4 2025 | 64 | 0 | 89.20M | $311.30M | n/a | n/a |
| Q3 2025 | 15 | -1 | 60.11M | $182.75M | +1 | −2 |
| Q2 2025 | 13 | 0 | 50.18M | $128.95M | +2 | −2 |
| Q1 2025 | 10 | 0 | 17.56M | $44.09M | +1 | −1 |
| Q4 2024 | 10 | 0 | 15.09M | $39.55M | +1 | −1 |
| Q3 2024 | 9 | 0 | 11.86M | $45.29M | +1 | −1 |
| Q2 2024 | 9 | n/a | 12.14M | $37.33M | n/a | n/a |
Who holds it · Q2 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 19.13M | n/a | $49.17M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 2 | ARK Investment Management ✦ | 10.05M | -8.3% | $25.82M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 3 | BlackRock ✦ (passive) | 8.36M | n/a | $21.49M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 4 | The Vanguard Group ✦ (passive) | 6.45M | n/a | $16.58M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 5 | Geode Capital Management ✦ (passive) | 2.45M | +22.5% | $6.29M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | State Street Global Advisors ✦ (passive) | 1.80M | +8.0% | $4.63M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Marshall Wace ✦ | 612.88K | New | $1.58M | 0.0% | New | 1 | SEC ↗ ×2 |
| 8 | Two Sigma Investments ✦ | 580.44K | +28.7% | $1.49M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Wellington Management ✦ | 378.26K | +17.1% | $972,130 | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
| 10 | Millennium Management ✦ | 229.96K | -78.6% | $590,995 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 60.64K | +9.2% | $155,850 | 0.0% | ▲ Add | 4 | SEC ↗ ×3 |
| 12 | T. Rowe Price ✦ | 54.70K | +56.3% | $141,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 17.91K | New | $46,024 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $1.58M | 0.0% |
| D. E. Shaw & Co. | $46,024 | 0.0% |
Exited
| Citadel Advisors | $2.39M | was 0.0% |
| Point72 Asset Management | $120,832 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 159 holders, 118.34M shares, $354.64M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2025 ·
Methodology ·
Get this via the API